CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary ...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing ...

Neither UTMB nor Moderna has confirmed the nature of the project included in the announcement, or how much funding is being ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future pandemics and innovations like cancer vaccines.

The Health and Human Services secretary canceled nearly $500 million in contracts related to the development of future ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...